| SKU | ISG002656 |
| Brand | Daonil |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 5 Mg |
| Shop by Concerns | High Blood Sugar |
| Gender | Neutral |
| Shop By Goals | Blood Thinning |
| Imported Or Local | Local |
| Ingredient | Glibenclamide |
| UPC | 6223003990510 |
| Product Form | Tablets |
| Specialty | Oral Antidiabetic Self-Cleaning |
| Sub Categories | Insulin And Diabetic Medicines |
| Unit Count | 30 Tablets |
| Warning | Avoid Use in Type 1 Diabetes Consult Doctor if Pregnant or Breastfeeding Use with Caution in Hepatic or Renal Impairment Risk of hypoglycemia |
Daonil 5 Mg 30 Tablets
Description:
Daonil 5 mg 30 tablets is an oral antidiabetic prescription medicine containing glibenclamide (also known as glyburide), a second-generation sulfonylurea. It is used as part of a comprehensive diabetes management plan to help control blood glucose levels in adults with type 2 diabetes mellitus. Daonil works by stimulating the pancreas to release more insulin and by improving the body’s response to insulin, thereby helping to reduce high blood sugar when diet and exercise alone are not sufficient.
Indications:
- Management of type 2 diabetes mellitus (non–insulin-dependent diabetes) in adults.
- Used when blood glucose levels are not adequately controlled by diet, physical activity, and weight reduction alone.
- May be used as monotherapy or in combination with other oral antidiabetic agents (such as metformin) as directed by a physician.
- Helps reduce symptoms and complications associated with uncontrolled hyperglycemia, such as excessive thirst, frequent urination, fatigue, and risk of long-term microvascular and macrovascular complications.
Active Ingredients / Key Components:
- Glibenclamide (Glyburide) – 5 mg per tablet.
- Excipients: The full list of inactive ingredients (such as fillers, binders, and coloring agents) is not available in the provided information. Please refer to the package leaflet for complete excipient details.
Dosage & Administration / How to Use:
- Dosage must always be individualized by the treating physician based on blood glucose monitoring, clinical response, and patient profile.
- Typical adult starting dose (general reference): often 2.5–5 mg once daily, taken with or immediately after breakfast or the first main meal of the day. The dose may be adjusted gradually by the doctor at intervals of several days to weeks.
- Maximum daily dose should not be exceeded as per prescribing information and physician’s instructions (exact maximum dose not provided here; consult the official leaflet and your doctor).
- Tablets should be swallowed whole with a glass of water, without crushing or chewing, unless otherwise directed by a healthcare professional.
- Take the medicine at the same time each day to maintain consistent blood levels and optimal glycemic control.
- Must be used together with a suitable diabetic diet, regular physical activity, and weight management as advised by your healthcare provider.
- If a dose is missed: take it as soon as you remember on the same day with food, unless it is almost time for the next dose. Do not double the dose to make up for a missed one, as this may increase the risk of hypoglycemia.
- Not recommended for use in type 1 diabetes, diabetic ketoacidosis, or in patients requiring insulin for glycemic control.
Clinical Benefits:
- Helps lower elevated blood glucose levels in adults with type 2 diabetes mellitus by stimulating insulin secretion from pancreatic beta cells.
- Improves glucose tolerance and enhances the body’s sensitivity to insulin at target tissues such as the liver, aiding better utilization of glucose.
- Contributes to reduction of diabetes-related symptoms like excessive thirst, frequent urination, and fatigue when used as part of a comprehensive treatment plan.
- Supports long-term prevention of diabetes complications (such as nerve, kidney, eye, and cardiovascular damage) when good glycemic control is maintained alongside lifestyle modifications.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity or allergy to glibenclamide, other sulfonylureas, sulfonamides, or any component of the formulation.
- Contraindicated in type 1 diabetes mellitus, diabetic ketoacidosis, diabetic pre-coma or coma, and in severe renal or hepatic impairment where insulin therapy is preferred.
- Use with caution in elderly patients, those with irregular meal patterns, malnutrition, adrenal or pituitary insufficiency, or conditions predisposing to hypoglycemia.
- Alcohol intake may potentiate the hypoglycemic effect and should be limited or avoided.
- May interact with other medicines (e.g., other antidiabetics, beta-blockers, ACE inhibitors, diuretics, corticosteroids, certain antibiotics, and others). Inform your doctor about all medications and supplements you are taking.
- Beta-blockers and some other drugs may mask the warning symptoms of hypoglycemia (such as palpitations and tremor); monitor blood glucose closely.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Insulin is often preferred during pregnancy; glibenclamide use in pregnancy or lactation must be strictly under medical supervision.
- Consult your doctor before use if you have liver disease, kidney disease, thyroid disorders, adrenal or pituitary problems, glucose-6-phosphate dehydrogenase (G6PD) deficiency, or cardiovascular disease.
- Avoid driving or operating machinery if you experience dizziness, blurred vision, or hypoglycemic episodes, as low blood sugar can impair concentration and reaction time.
- Not intended for use in children unless specifically prescribed by a specialist.
- Keep out of reach of children.
Side Effects:
- Common side effects: hypoglycemia (low blood sugar) with symptoms such as sweating, shakiness, hunger, headache, dizziness, palpitations, irritability, confusion, or difficulty concentrating. Mild hypoglycemia can often be treated by taking fast-acting carbohydrates (e.g., glucose tablets, sugary drink) as instructed by your doctor.
- Other possible side effects: nausea, vomiting, abdominal discomfort, diarrhea or constipation, skin reactions (rash, itching, redness), or photosensitivity.
- Rare but serious side effects: severe hypoglycemia requiring medical assistance, jaundice, liver function disturbances, blood disorders (e.g., thrombocytopenia, leukopenia, hemolytic anemia), or severe allergic reactions (swelling of face, lips, tongue, throat, or difficulty breathing).
- Stop the medication and seek immediate medical attention if you experience signs of severe hypoglycemia, allergic reaction, unusual bruising or bleeding, dark urine, yellowing of the skin or eyes, or persistent severe abdominal pain.
- This is not a complete list of side effects. For full safety information, refer to the official patient leaflet and consult your healthcare provider.
Storage Instructions:
Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack or container tightly closed. Do not store above the temperature recommended on the package (exact temperature not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); follow the pack instructions). Keep out of reach of children.
Specifications:
- Product type: Prescription oral antidiabetic medicine (sulfonylurea).
- Active ingredient strength: glibenclamide (glyburide) 5 mg per tablet.
- Form: Tablet.
- Pack size: 30 tablets per pack.
- Intended users: Adults with type 2 diabetes mellitus, as prescribed by a physician.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
